8 Hrs
Source:
BBC Home
_1777370193195_831968492.png&w=64&q=75){kind=small}
Source: BBC Home
8 HrsBBC Home
Source: BBC Home
8 HrsReady to play
Ready to play
The US Food and Drug Administration ordered makers of Ozempic, Wegovy, Mounjaro and Zepbound to warn that the drugs may be linked to rare NAION, an eye condition that can cause permanent vision loss. The FDA said its review found an increased risk, but Novo Nordisk and the American Academy of Ophthalmology said a cause-and-effect relationship has not been established. The academy advised patients not to stop medication without consulting a doctor and to seek prompt care for sudden, painless vision loss in one eye.
Notice: This Is an AI-Generated Summary
Comments (0)